Susan E. Lacy

579 total citations
14 papers, 465 citations indexed

About

Susan E. Lacy is a scholar working on Physiology, Health, Toxicology and Mutagenesis and Oncology. According to data from OpenAlex, Susan E. Lacy has authored 14 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Physiology, 3 papers in Health, Toxicology and Mutagenesis and 3 papers in Oncology. Recurrent topics in Susan E. Lacy's work include Air Quality and Health Impacts (2 papers), Smoking Behavior and Cessation (2 papers) and Blood groups and transfusion (2 papers). Susan E. Lacy is often cited by papers focused on Air Quality and Health Impacts (2 papers), Smoking Behavior and Cessation (2 papers) and Blood groups and transfusion (2 papers). Susan E. Lacy collaborates with scholars based in United States, Canada and Austria. Susan E. Lacy's co-authors include Peter Whyte, Carsten G. Bönnemann, Elizabeth A. Buzney, Louis M. Kunkel, Steve Coats, Matthew L. Fero, Grace Chung, James M. Roberts, Eduardo Firpo and Peter J. DeVries and has published in prestigious journals such as Blood, The Journal of Immunology and Cancer Research.

In The Last Decade

Susan E. Lacy

14 papers receiving 456 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susan E. Lacy United States 10 252 152 62 58 52 14 465
Tomoyo Yasui Japan 15 263 1.0× 202 1.3× 38 0.6× 64 1.1× 60 1.2× 58 637
Jiamin Teng United States 11 358 1.4× 76 0.5× 108 1.7× 74 1.3× 33 0.6× 21 441
R. Joel Welch United States 13 342 1.4× 152 1.0× 76 1.2× 54 0.9× 13 0.3× 40 729
Zamir Brelvi United States 8 298 1.2× 121 0.8× 46 0.7× 22 0.4× 54 1.0× 21 490
Mary A. Bewick Canada 13 225 0.9× 157 1.0× 13 0.2× 43 0.7× 39 0.8× 16 451
Carla de Boer Netherlands 11 244 1.0× 213 1.4× 17 0.3× 82 1.4× 61 1.2× 26 475
Wei‐Yu Lin United Kingdom 16 350 1.4× 123 0.8× 37 0.6× 32 0.6× 52 1.0× 44 667
Tim Crook United Kingdom 11 229 0.9× 276 1.8× 48 0.8× 40 0.7× 65 1.3× 16 678
Élisabeth Daguenet France 11 298 1.2× 126 0.8× 15 0.2× 26 0.4× 45 0.9× 45 609
Toshihide Nishishita Japan 12 325 1.3× 101 0.7× 29 0.5× 16 0.3× 42 0.8× 13 476

Countries citing papers authored by Susan E. Lacy

Since Specialization
Citations

This map shows the geographic impact of Susan E. Lacy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan E. Lacy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan E. Lacy more than expected).

Fields of papers citing papers by Susan E. Lacy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan E. Lacy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan E. Lacy. The network helps show where Susan E. Lacy may publish in the future.

Co-authorship network of co-authors of Susan E. Lacy

This figure shows the co-authorship network connecting the top 25 collaborators of Susan E. Lacy. A scholar is included among the top collaborators of Susan E. Lacy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan E. Lacy. Susan E. Lacy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Powderly, John D., Toshio Shimizu, Patricia LoRusso, et al.. (2021). Abstract CT207: Phase 1 first-in-human study of ABBV-151 as monotherapy or in combination with budigalimab in patients with locally advanced or metastatic solid tumors. Cancer Research. 81(13_Supplement). CT207–CT207. 3 indexed citations
2.
3.
McGaraughty, Steve, Rachel Davis‐Taber, Chang Zhu, et al.. (2017). Targeting Anti–TGF-β Therapy to Fibrotic Kidneys with a Dual Specificity Antibody Approach. Journal of the American Society of Nephrology. 28(12). 3616–3626. 42 indexed citations
4.
5.
Lacy, Susan E., Christopher J. Bond, Dennis R. Benjamin, et al.. (2009). Americas Antibody Congress. mAbs. 1(6). 523–530. 3 indexed citations
6.
Lacy, Susan E., et al.. (2008). The Potency of Erythropoietin-Mimic Antibodies Correlates Inversely with Affinity. The Journal of Immunology. 181(2). 1282–1287. 22 indexed citations
7.
Liu, Zhihong, Vincent S. Stoll, Peter J. DeVries, et al.. (2007). A potent erythropoietin-mimicking human antibody interacts through a novel binding site. Blood. 110(7). 2408–2413. 35 indexed citations
8.
Lacy, Susan E., Carsten G. Bönnemann, Elizabeth A. Buzney, & Louis M. Kunkel. (1999). Identification of FLRT1, FLRT2, and FLRT3: A Novel Family of Transmembrane Leucine-Rich Repeat Proteins. Genomics. 62(3). 417–426. 96 indexed citations
9.
Coats, Steve, Peter Whyte, Matthew L. Fero, et al.. (1999). A new pathway for mitogen-dependent Cdk2 regulation uncovered in p27Kip1-deficient cells. Current Biology. 9(4). 163–173. 107 indexed citations
10.
Lacy, Susan E. & Peter Whyte. (1997). Identification of a p130 domain mediating interactions with cyclin A/cdk 2 and cyclin E/cdk 2 complexes. Oncogene. 14(20). 2395–2406. 51 indexed citations
11.
Olsen, Geary W., et al.. (1994). Retrospective cohort mortality study of workers with potential exposure to epichlorohydrin and allyl chloride. American Journal of Industrial Medicine. 25(2). 205–218. 6 indexed citations
12.
Olsen, Geary W., et al.. (1994). Half‐century of cause‐specific mortality experience of chemical manufacturing employees. American Journal of Industrial Medicine. 26(2). 203–219. 10 indexed citations
13.
Olsen, Geary W., et al.. (1991). A 5-year evaluation of a smoking cessation incentive program for chemical employees. Preventive Medicine. 20(6). 774–784. 20 indexed citations
14.
Olsen, Geary W., et al.. (1990). A Smoking Cessation Incentive Program for Chemical Employees: Design and Evaluation. American Journal of Preventive Medicine. 6(4). 200–207. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tomoyo Yasui Breakdown of academic impact, for papers by Jiamin Teng Breakdown of academic impact, for papers by R. Joel Welch Breakdown of academic impact, for papers by Zamir Brelvi Breakdown of academic impact, for papers by Mary A. Bewick Breakdown of academic impact, for papers by Carla de Boer Breakdown of academic impact, for papers by Wei‐Yu Lin Breakdown of academic impact, for papers by Tim Crook Breakdown of academic impact, for papers by Élisabeth Daguenet Breakdown of academic impact, for papers by Toshihide Nishishita
Rankless by CCL
2026